NEW YORK, Sept. 15, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Depomed, Inc. ("Depomed") (NASDAQ:DEPO) between February 26, 2015 and August 7, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of California. To get more information go to:
http://www.zlk.com/plsra-c/depomed-inc?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Depomed engaged in questionable practices in connection with the sales and marketing of the Company’s opioid products; (ii) the foregoing conduct, when it became known, would likely subject the Company to heightened legal and regulatory scrutiny; and (iii) as a result, Depomed’s public statements were materially false and misleading at all relevant times.
On August 7, 2017, post-market, Depomed disclosed that the Company “received a request for information from the ranking minority member of the United States Senate Committee on Homeland Security and Governmental Affairs related to the promotion of opioids” and that the Company had received “subpoenas related to opioid sales and marketing from the Office of the Attorney General of Maryland and the United States Department of Justice.”
If you suffered a loss in Depomed you have until October 17, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com


Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Apple Turns 50: From Garage Startup to AI Crossroads
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 



